Dose Selection Based on Modeling and Simulation for Rivipansel in Pediatric Patients Aged 6 to 11 Years With Sickle Cell Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 2163-8306|6|12|845-854

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.6, Iss.12, 2017-12, pp. : 845-854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Z and Endothelin‐1 genetic polymorphisms in pediatric Egyptian sickle cell disease patients

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Model‐Based Once‐Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV‐1‐Infected Patients Aged ≥3 to

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 7, 2015-08 ,pp. : 406-414

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sickle cell disease

By Yardumian Anne   Crawley Charles  

Clinical Medicine, Vol. 1, Iss. 6, 2001-11 ,pp. : 441-446

Royal College Of Physicians

Access to resources Recommend Favorite

Sickle Cell Disease in Children

By >   Miller Jeffery L.  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 895-906

Adis International

Access to resources Recommend Favorite

Sildenafil resolved priapism in 3 patients with sickle cell disease

By  

Inpharma, Vol. 1, Iss. 1357, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite